259 related articles for article (PubMed ID: 25408159)
21. RNAi using a chitosan/siRNA nanoparticle system: in vitro and in vivo applications.
Andersen MØ; Howard KA; Kjems J
Methods Mol Biol; 2009; 555():77-86. PubMed ID: 19495689
[TBL] [Abstract][Full Text] [Related]
22. Introduction of stearoyl moieties into a biocompatible cationic polyaspartamide derivative, PAsp(DET), with endosomal escaping function for enhanced siRNA-mediated gene knockdown.
Kim HJ; Ishii A; Miyata K; Lee Y; Wu S; Oba M; Nishiyama N; Kataoka K
J Control Release; 2010 Jul; 145(2):141-8. PubMed ID: 20359509
[TBL] [Abstract][Full Text] [Related]
23. Targeting Pro-Tumoral Macrophages in Early Primary and Metastatic Breast Tumors with the CD206-Binding mUNO Peptide.
Lepland A; Asciutto EK; Malfanti A; Simón-Gracia L; Sidorenko V; Vicent MJ; Teesalu T; Scodeller P
Mol Pharm; 2020 Jul; 17(7):2518-2531. PubMed ID: 32421341
[TBL] [Abstract][Full Text] [Related]
24. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
[TBL] [Abstract][Full Text] [Related]
25. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.
Mao CQ; Du JZ; Sun TM; Yao YD; Zhang PZ; Song EW; Wang J
Biomaterials; 2011 Apr; 32(11):3124-33. PubMed ID: 21277018
[TBL] [Abstract][Full Text] [Related]
26. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
[TBL] [Abstract][Full Text] [Related]
27. Polycationic nanoparticles for siRNA delivery: comparing ARGET ATRP and UV-initiated formulations.
Forbes DC; Peppas NA
ACS Nano; 2014 Mar; 8(3):2908-17. PubMed ID: 24548237
[TBL] [Abstract][Full Text] [Related]
28. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery.
Tanaka K; Kanazawa T; Horiuchi S; Ando T; Sugawara K; Takashima Y; Seta Y; Okada H
Int J Pharm; 2013 Oct; 455(1-2):40-7. PubMed ID: 23911914
[TBL] [Abstract][Full Text] [Related]
29. Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice.
Yhee JY; Lee SJ; Lee S; Song S; Min HS; Kang SW; Son S; Jeong SY; Kwon IC; Kim SH; Kim K
Bioconjug Chem; 2013 Nov; 24(11):1850-60. PubMed ID: 24107100
[TBL] [Abstract][Full Text] [Related]
30. Self-assembled carboxymethyl poly (L-histidine) coated poly (β-amino ester)/DNA complexes for gene transfection.
Gu J; Wang X; Jiang X; Chen Y; Chen L; Fang X; Sha X
Biomaterials; 2012 Jan; 33(2):644-58. PubMed ID: 22030282
[TBL] [Abstract][Full Text] [Related]
31. Tumour-associated macrophages targeted transfection with NF-κB decoy/mannose-modified bubble lipoplexes inhibits tumour growth in tumour-bearing mice.
Kono Y; Kawakami S; Higuchi Y; Maruyama K; Yamashita F; Hashida M
J Drug Target; 2014 Jun; 22(5):439-49. PubMed ID: 24579693
[TBL] [Abstract][Full Text] [Related]
32. Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression.
Wang R; Zhang J; Chen S; Lu M; Luo X; Yao S; Liu S; Qin Y; Chen H
Lung Cancer; 2011 Nov; 74(2):188-96. PubMed ID: 21601305
[TBL] [Abstract][Full Text] [Related]
33. Polymeric nanocarriers for siRNA delivery to murine macrophages.
Forbes DC; Peppas NA
Macromol Biosci; 2014 Aug; 14(8):1096-105. PubMed ID: 24753265
[TBL] [Abstract][Full Text] [Related]
34. Efficient and Targeted siRNA Delivery to M2 Macrophages by Smart Polymer Blends for M1 Macrophage Repolarization as a Promising Strategy for Future Cancer Treatment.
Jürgens DC; Winkeljann B; Kolog Gulko M; Jin Y; Möller J; Winkeljann J; Sheshachala S; Anger A; Hörner A; Adams NBP; Urbanetz N; Merkel OM
ACS Biomater Sci Eng; 2024 Jan; 10(1):166-177. PubMed ID: 37978912
[TBL] [Abstract][Full Text] [Related]
35. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
[TBL] [Abstract][Full Text] [Related]
36. Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer.
Chen S; He Y; Huang X; Shen Y; Zou Q; Yang G; Fu L; Liu Q; Luo D
J Nanobiotechnology; 2024 Jun; 22(1):348. PubMed ID: 38898486
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
38. Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo.
Li K; Lu L; Xue C; Liu J; He Y; Zhou J; Xia Z; Dai L; Luo Z; Mao Y; Cai K
Nanoscale; 2020 Jan; 12(1):130-144. PubMed ID: 31799577
[TBL] [Abstract][Full Text] [Related]
39. Suppression of Hepatic Inflammation via Systemic siRNA Delivery by Membrane-Disruptive and Endosomolytic Helical Polypeptide Hybrid Nanoparticles.
He H; Zheng N; Song Z; Kim KH; Yao C; Zhang R; Zhang C; Huang Y; Uckun FM; Cheng J; Zhang Y; Yin L
ACS Nano; 2016 Feb; 10(2):1859-70. PubMed ID: 26811880
[TBL] [Abstract][Full Text] [Related]
40. Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages.
He C; Yin L; Tang C; Yin C
Biomaterials; 2013 Apr; 34(11):2843-54. PubMed ID: 23347838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
